Maintained Intraocular Pressure Reduction With Once-a-Day Application of a New Prostaglandin F2α Analogue (PhXA41)
- 1 May 1993
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 111 (5) , 657-661
- https://doi.org/10.1001/archopht.1993.01090050091036
Abstract
Research from JAMA Ophthalmology — Maintained Intraocular Pressure Reduction With Once-a-Day Application of a New Prostaglandin F2α Analogue (PhXA41) — An In-Hospital, Placebo-Controlled StudyKeywords
This publication has 9 references indexed in Scilit:
- Effects of a new PGF2α analog on aqueous humor dynamics in human eyes: Torie, C., Camras, C. and Yablonski, M. Dept. of Ophthalmology, Univ. of Nebraska Medical Center, Omaha, Nebraska, USAExperimental Eye Research, 1992
- Compliance with Medical Treatment of GlaucomaJournal of Glaucoma, 1992
- Phenyl substituted prostaglandin analogs for glaucoma treatmentDrugs of the Future, 1992
- Ocular effects of two different prostaglandin F2α estersActa Ophthalmologica, 1990
- Prostaglandin F2α increases uveoscleral outflow in the cynomolgus monkeyExperimental Eye Research, 1989
- Prostaglandin F2α-1-Isopropylester Lowers Intraocular Pressure Without Decreasing Aqueous Humor FlowAmerican Journal of Ophthalmology, 1988
- Compliance with Topical Pilocarpine TreatmentPublished by Elsevier ,1986
- The effects of prostaglandin F2α in the human eyeAlbrecht von Graefes Archiv für Ophthalmologie, 1985
- Comparison of the ocular hypotensive efficacy of eicosanoids and related compoundsExperimental Eye Research, 1984